JP2008512445A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512445A5
JP2008512445A5 JP2007530849A JP2007530849A JP2008512445A5 JP 2008512445 A5 JP2008512445 A5 JP 2008512445A5 JP 2007530849 A JP2007530849 A JP 2007530849A JP 2007530849 A JP2007530849 A JP 2007530849A JP 2008512445 A5 JP2008512445 A5 JP 2008512445A5
Authority
JP
Japan
Prior art keywords
derivative
liposome
pharmaceutical composition
composition according
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512445A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2005/000962 external-priority patent/WO2006027786A2/en
Publication of JP2008512445A publication Critical patent/JP2008512445A/ja
Publication of JP2008512445A5 publication Critical patent/JP2008512445A5/ja
Pending legal-status Critical Current

Links

JP2007530849A 2004-09-09 2005-09-11 炎症状態の治療のためのリポソーム性グルココルチコイドの使用 Pending JP2008512445A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60814004P 2004-09-09 2004-09-09
PCT/IL2005/000962 WO2006027786A2 (en) 2004-09-09 2005-09-11 Use of liposomal glucocorticoids for treating inflammatory states

Publications (2)

Publication Number Publication Date
JP2008512445A JP2008512445A (ja) 2008-04-24
JP2008512445A5 true JP2008512445A5 (enExample) 2008-10-30

Family

ID=35432741

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007530850A Expired - Fee Related JP5355890B2 (ja) 2004-09-09 2005-09-11 グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
JP2007530849A Pending JP2008512445A (ja) 2004-09-09 2005-09-11 炎症状態の治療のためのリポソーム性グルココルチコイドの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007530850A Expired - Fee Related JP5355890B2 (ja) 2004-09-09 2005-09-11 グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物

Country Status (7)

Country Link
US (3) US7744920B2 (enExample)
EP (2) EP1793804A2 (enExample)
JP (2) JP5355890B2 (enExample)
CN (2) CN101048138B (enExample)
AU (2) AU2005281352B2 (enExample)
CA (2) CA2579695A1 (enExample)
WO (2) WO2006027786A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
KR20060015534A (ko) 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
AU2005281352B2 (en) * 2004-09-09 2011-01-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
DE102007060199A1 (de) 2007-12-14 2009-06-18 Osram Gesellschaft mit beschränkter Haftung Leuchtstoff und Beleuchtungssystem mit derartigem Leuchtstoff
DE102007060198A1 (de) 2007-12-14 2009-06-18 Osram Gesellschaft mit beschränkter Haftung Konversions-LED
JP5542804B2 (ja) * 2008-05-23 2014-07-09 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア リポソームナノ粒子中で使用するための修飾薬物
EP2127639A1 (en) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid containing liposomes for treatment of cardiovascular diseases
CN101601652B (zh) * 2008-06-11 2012-07-04 天津金耀集团有限公司 糠酸莫米松脂质体乳膏
ES2919563T3 (es) * 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
WO2011092708A2 (en) * 2010-02-01 2011-08-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomes comprising amphipathic drugs and method for their preparation
JP2011246464A (ja) * 2010-04-28 2011-12-08 Wakamoto Pharmaceutical Co Ltd ジクロフェナクナトリウムを封入した後眼部到達用ポリマーコーティングリポソーム
AU2011353698B2 (en) 2011-01-05 2017-05-11 Livon Laboratories Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
US20140328759A1 (en) 2011-10-25 2014-11-06 The University Of British Columbia Limit size lipid nanoparticles and related methods
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
BR112015000174A2 (pt) 2012-07-05 2017-06-27 Taiwan Liposome Co Ltd método para o tratamento da artrite
CN103083239B (zh) * 2012-12-26 2015-11-25 中国人民解放军第四军医大学 一种蟾毒灵脂质体及其制备方法和应用
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
JP6151786B2 (ja) * 2013-09-30 2017-06-21 富士フイルム株式会社 医療支援装置、医療支援装置の制御方法、医療支援プログラム及び医療支援システム
US20150132369A1 (en) * 2013-11-09 2015-05-14 Exir Nano Sina Company Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof
CN103720658B (zh) * 2014-01-07 2015-10-07 中国药科大学 肝素修饰的阿霉素脂质体制剂及其制备方法
SG10201912650QA (en) * 2015-12-17 2020-02-27 Univ Nanyang Tech Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them
TWI754659B (zh) * 2016-08-08 2022-02-11 台灣微脂體股份有限公司 用於製備含有弱酸性劑之微脂體組合物的傳輸載體、方法及套組
EP3658134A4 (en) 2017-07-24 2021-05-05 Pharmosa Biopharm Inc. LIPOSOME COMPOSITIONS WITH WEAK ACID MEDICINAL PRODUCTS AND USES THEREOF
WO2019046233A1 (en) * 2017-08-30 2019-03-07 Bristol-Myers Squibb Company METHOD FOR MONITORING PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO DELIVERY OF GLUCOCORTICOIDS
SG11202011045VA (en) 2018-05-07 2020-12-30 Pharmosa Biopharm Inc Pharmaceutical composition for controlled release of treprostinil
TWI755629B (zh) * 2018-09-13 2022-02-21 台灣微脂體股份有限公司 含鎮靜藥物之緩釋藥物組合物及其用途
US20200085741A1 (en) * 2018-09-14 2020-03-19 Pharmosa Biopharm Inc. Pharmaceutical composition for controlled release of weak acid drugs and uses thereof
KR102164260B1 (ko) * 2018-10-30 2020-10-12 (주)유에이치에이 메틸프레드니솔론 및 줄기세포를 유효성분으로 포함하는 다발성 경화증의 예방 또는 치료용 조성물
CN113827738B (zh) * 2020-06-08 2024-04-09 沈阳药科大学 唾液酸修饰地塞米松棕榈酸酯脂质体及其制备和应用
CN116077465B (zh) * 2022-02-25 2024-05-24 中南大学湘雅医院 用于关节镇痛的纳米制剂及其制备方法和应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56161317A (en) * 1980-05-15 1981-12-11 Green Cross Corp:The Pharmaceutical preparation of fatty corpuscle of steroid
US4757056A (en) * 1984-03-05 1988-07-12 Hepar Industries, Inc. Method for tumor regression in rats, mice and hamsters using hexuronyl hexosaminoglycan-containing compositions
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
WO1990006775A1 (en) 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5189018A (en) * 1991-08-19 1993-02-23 Wayne State University Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
US5817856A (en) * 1995-12-11 1998-10-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiation-protective phospholipid and method
DE19607722A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Dr Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung
ATE252372T1 (de) 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
WO1998016201A1 (en) * 1996-10-11 1998-04-23 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US20030185826A1 (en) * 1999-02-24 2003-10-02 Tobinick Edward L. Cytokine antagonists for the treatment of localized disorders
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
JP4623931B2 (ja) * 2000-12-07 2011-02-02 エンセラデュス、ファーマシューティカルズ、ベスローテン、フェンノートシャップ 炎症性疾患の治療用組成物
WO2002064110A2 (en) * 2001-02-13 2002-08-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Carotenoid-loaded liposomes
BR0211110B1 (pt) 2001-07-11 2009-05-05 atadeira para jardinagem.
AU2002334358B2 (en) * 2001-09-06 2008-02-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparing liposome formulations with a predefined release profile
US20040219201A1 (en) 2001-12-06 2004-11-04 Yechezkel Barenholz Tempamine compositions and methods of use
AU2003259028A1 (en) * 2002-06-10 2003-12-22 Combinatorx, Incorporated Combinations for the treatment of rheumatoid arthritis
EP1371362A1 (en) * 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
WO2004004640A2 (en) * 2002-07-05 2004-01-15 Tetragrammaton Inc. Methods, compositions and kits for treating damage to excitable tissue
EP1393720A1 (en) 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US20060025446A1 (en) * 2004-07-27 2006-02-02 Jeffrey Sterling Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
AU2005281352B2 (en) * 2004-09-09 2011-01-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
WO2008118013A2 (en) * 2007-03-23 2008-10-02 To-Bbb Holding B.V. Targeted intracellular delivery of antiviral agents

Similar Documents

Publication Publication Date Title
JP2008512446A5 (enExample)
JP5355890B2 (ja) グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
RU2468797C2 (ru) Способ и композиция для лечения воспалительных нарушений
JP5645340B2 (ja) 活性成分を含有するカチオンリポソームの投与方法
US8653129B2 (en) Combination therapy for skin disorders
ES2875742T3 (es) Métodos para aumentar la inhibición tónica y tratamiento del síndrome de Angelman
JP4869594B2 (ja) 癌治療のための小胞封入コルチコステロイド
US20180340005A1 (en) Conjugated Neuroactive Steroid Compositions And Methods Of Use
BRPI0615032A2 (pt) composição farmacêutica, processo para a preparação da mesma, e, uso de uma composição
PT100087B (pt) Novos esteres de esteroides
JP4623931B2 (ja) 炎症性疾患の治療用組成物
CN104144679A (zh) 用于治疗人类炎症性疾病的脂质体皮质类固醇
JP2004509854A (ja) バルプロ酸のリン脂質誘導体およびそれらの混合物
TW202007398A (zh) 減少關節內類固醇的併發症之方法
JP2008512444A (ja) 神経変性状態の治療のための、両親媒性弱塩基様テンパミンを含むリポソーム製剤
CN101193622A (zh) 治疗炎性疾病的方法和组合物
JP2016050181A (ja) 血管炎治療剤
JPWO2017222042A1 (ja) 眼用医薬組成物
US20240398725A1 (en) Nanoparticles for cancer treatment
US20240325359A1 (en) Acat1 inhibitor and method of use in the treatment of disease
HK40070194A (en) Compositions and methods for delivery of therapeutic agents
WO1994025017A1 (fr) PREPARATION PERNASALE A BASE DE threo-3-(3,4-DIHYDROXYPHENYL)SERINE
US20200281950A1 (en) Liposomes for treatment of an autoimmune disease
HK40041258A (en) Methods to reduce complications of intra-articular steroid